Khan et al identified risk groups for patients undergoing renal replacement therapy. A patient at higher risk may benefit from more aggressive management or treatment with a novel therapy. The authors are from the University of Aberdeen, Aberdeen Royal Infirmary and Ninewells Hospital in Dundee.
